Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Top Economists Forecast Inflation to Reach 6 in Q2 Amid Persistent Price Pressures Eli Lillys NextGeneration Obesity Drug Retatrutide Shows Positive Results in Pivotal Trial AI Job Applications Create a Doom Loop for Recruiters and Candidates Illinois Payrolls Rise in March Unemployment Rate Edges Higher HPs Strategy Chief Sees Edge AI as Key to Reducing Token Costs Amid AI PC Sales Growth Heartcore Enterprises Inc HTCR Q2 2025 Earnings Massive EPS Beat Drives DoubleDigit Stock Surge PAM Q1 2026 Earnings Staggering EPS Beat as Operating Performance Surges FTHM Q4 2025 Earnings EPS Misses Estimates as Losses Widen Stock Edges Higher JBGS Q1 2026 Earnings Positive EPS Marks a Step Forward Amidst Market Uncertainty Skye Bioscience Inc SKYE Q1 2026 Earnings EPS Slightly Misses Estimates as Stock Surges on Pipeline Progress ProQR Therapeutics PRQR Soars 83 Analyzing the Rally and Key Levels to Watch Allegion ALLE Shows Mild Uptick as Support Levels Hold Firm Kayne Anderson Energy Infrastructure Fund KYN Nears Support After Modest Decline Sagimet Biosciences SGMT Edges Higher as Clinical Momentum Builds US Payrolls Surge in April but Underlying Weaknesses Raise Economists Concerns IBMs 2026 Outlook Banking and Financial Markets Poised for Transformation Nvidia Stock Approaches Critical Technical Level Market Watchers Eye Potential Directional Move Singapore Sees Surge in Russian Oil Arrivals as Trade Flows Adapt to Sanctions G7 Disunity Deepens as Member States Reportedly Drop Plans for 2026 Joint Communique BofA Lowers Royal Gold Price Target After Company Reduces Hod Maden Stake to 15 DoubleDigit Earnings Growth May Not Shield Markets from Bear Turn History Suggests Reliance Industries Sets AGM Date for June 2026 Announces Dividend Record Date Kazatomprom Reports 17 Production Increase in Third Quarter Signaling Strong Operational Momentum Suratbased Anupam Rasayan India to Acquire Up to 742 Stake in Bliss GVS Pharma in Deal Worth Over Rs 1360 Crore